Osimertinib-related venous thromboembolism in non small lung cancer

Thromb Res. 2022 Feb:210:63-66. doi: 10.1016/j.thromres.2021.12.019. Epub 2021 Dec 29.
No abstract available

Keywords: EGFR; Lung cancer; Osimertinib; Risk; Thrombosis.

Publication types

  • Letter

MeSH terms

  • Acrylamides / adverse effects
  • Aniline Compounds / adverse effects
  • Humans
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / drug therapy
  • Mutation
  • Protein Kinase Inhibitors
  • Venous Thromboembolism* / drug therapy

Substances

  • Acrylamides
  • Aniline Compounds
  • Protein Kinase Inhibitors
  • osimertinib